This independent review has explored the challenges faced by individuals who are addicted to alcohol or drugs, or are obese, when they seek to enter, return to and/or remain in work (UK Government)
Bibliography: Interventions – Harm Reduction
Understanding the patterns of use, motives, and harms of New Psychoactive Substances in Scotland
Findings are presented on patterns of NPS use, motivations for and consequences of use, and treatment and legislative responses. 133-page PDF (Scottish Government)
The public health burden of alcohol: evidence review
This review looks at the impact of alcohol on the public health and the effectiveness of alcohol control policies (Public Health England)
PHE publishes alcohol evidence review
The review looks at the evidence on alcohol harm and its impact in England (Public Health England)
HIV and Injection Drug Use
Syringe Services Programs for HIV Prevention (CDC)
Understanding the patterns of use, motives, and harms of New Psychoactive Substances in Scotland (PDF)
Findings are presented on patterns of NPS use, motivations for and consequences of use, and treatment and legislative responses (Scottish Government)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network (PDF)
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report is based on the indicator’s annual expert meeting, held in Lisbon in June 2016, which brought together national experts from the 28 EU Member States, Norway and Turkey (EMCDDA)
ALCOHOL and cancer trends: intervention scenarios (PDF)
Projecting trends in alcohol consumption and alcohol-related harm in England from 2015 to 2035 and estimating the impact of potential minimum unit pricing and taxation policies (Cancer Research UK)
Global State of Harm Reduction 2016
Services to reduce drug-related harms are failing to keep up with growing need, despite pledges to combat AIDS among people who inject drugs (HRI)
Health and Justice Commissioning Intentions 2017/18 (PDF)
This document sets out NHS England’s national commissioning intentions for healthcare services in secure and detained settings, sexual assault referral centres and liaison and diversion for 2017/18 (NHS England)
Monitoring the legal provision of foil to heroin users (PDF)
This report presents findings from research designed to explore how legislation to allow the lawful supply of foil to heroin users by drug treatment services has operated in practice (Home Office)
Physical health of people in prison
NICE guideline [NG57]
Alcohol, drugs and tobacco joint strategic needs assessment support packs
These joint strategic needs assessment (JSNA) support packs – updated annually and in their third year – will help local areas to develop JSNAs and local joint health and wellbeing strategies, which effectively address public health issues (Public Health England)
We must escalate efforts to prevent drug-related deaths
Deaths caused by drug misuse are rising. In order to help us take effective action we need to better understand the multiple and complex causes behind this disturbing trend (Public Health England)
Public Health England Health & Justice annual review 2015/16 (PDF)
4.3 Preventing and reducing substance misuse in the CJS
National Naloxone Programme Scotland Monitoring Report 2015/16 (PDF)
This report from ISD presents information on the number of THN kits issued as part of the NNP (from 2011/12 to 2015/16)
Safer consumption facility and treatment service pilot (PDF)
The report aims to advise the Integration Joint Board the outcomes of the Alcohol and Drug Partnership short-life working group and its decision, following a formal options appraisal, to support the piloting of a co-located safer drug consumption facility and heroin assisted treatment service in (Glasgow city centreGlasgow City Integration Joint Board)
Hepatitis C in the UK
The most recent national estimates suggest that around 214,000 individuals are chronically infected with hepatitis C virus (HCV) in the UK (Public Health England)
The National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (PDF)
Our annual report is the point in each year when we assess progress on safety in mental health care across the UK. It provides the latest figures on tragic events – suicides, homicides and sudden deaths – and highlights the priorities for safer services (HQIP)
Public health successes and missed opportunities (PDF)
Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990–2014
Alcohol’s harms to others
The harms from other people’s alcohol consumption in Wales (Public Health Wales)
The CUPID Project: Understanding and preventing hepatitis C transmission within heterosexual couples
Main findings and recommendations for policy and practice (UNSW, Australia)
Prevention of harm caused by alcohol exposure in pregnancy
Rapid review and case studies from Member States (WHO)
Taking away the chaos (PDF)
The health needs of people who inject drugs in public places in Glasgow city centre (NHS)
Understanding and preventing drug-related deaths
The report of a national expert working group to investigate drug-related deaths in England (Public Health England)
The health impacts of alcohol (PDF)
This factsheet provides an overview of how alcohol effects individuals’ health and also the population levels of alcohol related morbidity and mortality in the UK (IAS)
UK Chief Medical Officers’ Low Risk Drinking Guidelines (PDF)
At the request of the UK Chief Medical Officers (CMOs), three groups of independent experts met between 2013 and 2016 to consider the evidence on the health effects of alcohol and whether this could form the basis of new advice for the public (Department of Health, UK)
Alcohol CLeaR self-assessment tool
CLeaR provides a framework for strategic review and analysis of local structures and delivery focusing on local outcomes and priorities (Public Health England)
FDA Supports Greater Access to Naloxone to Help Reduce Opioid Overdose Death
One option to do this is identifying ways to assist manufacturers in submitting an application to the FDA for an over-the-counter (OTC) version of a naloxone product
A Healthier Start: Addressing Neonatal Abstinence Syndrome and Opioid Misuse during Pregnancy
In collaboration with partners across federal government, SAMHSA is sharpening its focus on opioid-dependent pregnant women. And with a $1 billion, two-year investment of new, mandatory funding in the President’s Fiscal Year (FY) 2017 Budget proposal to bolster our efforts, we’re expanding and intensifying our work to prevent and treat opioid dependence, including identification and treatment of NAS
New Psychoactive Substances (NPS) resource pack
A resource pack on new psychoactive substances for educators and practitioners working with young people (Home Office)
Hepatitis C among drug users in Europe: epidemiology, treatment and prevention
A state of the art review of the epidemiology of hepatitis C virus (HCV) infection in Europe and an overview of the way preventive measures are currently implemented in European countries set the scene (EMCDDA)
Families Affected by Parental Substance Use
The purposes of this clinical report are to review some of the short-term effects of maternal substance use during pregnancy and long-term implications of fetal exposure; describe typical medical, psychiatric, and behavioral symptoms of children and adolescents in families affected by substance use; and suggest proficiencies for pediatricians involved in the care of children and adolescents of families affected by substance use, including screening families, mandated reporting requirements, and directing families to community, regional, and state resources that can address needs and problems (Pediatrics)
Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization
Buprenorphine (often prescribed with naloxone, as “suboxone”) is an evidence-based medication for people with opioid use disorder. Clinical wisdom suggests staying on the medication consistently is important to patient outcomes. But does consistent adherence really make a difference? (Recovery Research Review)
People who inject drugs: HIV and viral hepatitis monitoring
Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (Public Health England)
Widening the availability of naloxone
(Department of Health)
Health responses to new psychoactive substances
This short report provides an overview of the current situation in terms of NPS use and harms across Europe and reviews the available health- and drug-related interventions in that area (EMCDDA)
Delivering alcohol IBA in housing, probation and social work settings: opportunities and constraints (PDF)
Three case studies to examine the issues that arise in attempting to introduce and sustain the delivery of IBA into everyday practice in housing, probation and social work contexts (Drug and Alcohol Research Centre Middlesex University)
People who inject drugs have other priorities ahead of PrEP
With limited availability of harm reduction services, poor access to HIV treatment and little progress on legal reform, respondents suggested that people who inject drugs have more pressing needs than PrEP (aidsmap)
New Psychoactive Drugs: No Easy Answer
This paper will advance policymakers’ knowledge and thinking about this developing issue (Policy Talk)
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- Next Page »
